from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2148c/-

LFCtreatmentdescriptionclass of inhibitor

-0.170

Amikacinug/mL Amikacintranslation

-0.017

Cap5-10ug/mL Capreomycintranslation

-0.130

Rox10-50 ug/mL Roxithromycintranslation

0.193

SM2-5 ug/mL Streptomycintranslation

1.717

Tet5-10 ug/mL Tetracyclinetranslation

0.639

Rif0.2-5ug/mL Rifampicintranscription

-0.580

Rifp0.1-0.5ug/mL Rifapentinetranscription

-3.542

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.885

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.528

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.034

Clofazimine10-13 ug/mL Clofaziminerespiration

0.090

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.275

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.228

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.902

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.323

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.619

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.018

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.076

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.182

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.385

KCN5-20 ug/mL Potassium cyaniderespiration

0.913

NaN30.2-2 mM Sodium aziderespiration

-0.655

Nigericin50 uM Nigericinrespiration

0.434

TRC10-150 ug/mL Triclosanrespiration

0.032

TRZ10-25 ug/mL Thioridazinerespiration

-1.638

Valinomycin0.5-10 uM Valinomycinrespiration

4.766

ZnSO42 mM ZnSO4respiration

-0.983

menadione6-10 ug/mL Menadionerespiration

-0.050

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.527

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.055

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.021

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.014

NRP_1Non-replicating persistence stage 1dosRassociated

-0.230

Amp0.2mg/mL AmpicillincellWall

0.073

Cephalexin20-100 ug/mL CephalexincellWall

-0.179

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.280

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.360

EMB10-20 ug/mL EthambutolcellWall

-0.252

Eta12-40 ug/mL EthionamidecellWall

0.118

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.369

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.896

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.489

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.431

BZA0.12 mg/mL BenzamidearomaticAmides

0.391

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.158

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.884

H2O24 mM hydrogen peroxideDNAdamaging

-0.327

Levo10 ug/mL LevofloxacinDNAdamaging

0.425

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.665

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.179

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.018

UVUV-irradiationDNAdamaging

-0.635

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.938

Antimycin12.5-50 ug/mL Antimycin A?

-0.313

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.403

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.241

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.313

PA8240.2-2 ug/mL PA-824?

1.385

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.214

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.623

Verapamil50 uM Verapamil?

-1.055

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.416

methoxatin10-20 ug/mL Methoxatin?